Chen Tianhui, Chen Zhongxing, Du Juan, Zhang Min, Chen Zexu, Gao Qingyi, Chen Aodong, Meng Qinghao, Sun Yang, Liu Yan, Song Linghao, Wang Xinyue, Edavi Pranav Prakash, Xu Chen, Zhang Hongmei, Huang Jinhai, Jiang Yongxiang
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, 200031, China.
Bioact Mater. 2024 Dec 4;45:446-458. doi: 10.1016/j.bioactmat.2024.11.031. eCollection 2025 Mar.
Ectopia lentis (EL), characterised by impaired zonular fibers originating from non-pigmented ciliary epithelial cells (NPCEC), presents formidable surgical complexities and potential risks of visual impairment. Cataract surgery is the only treatment method for EL, but it leads to the loss of accommodative power of the lens post-operatively. Furthermore, the challenge of repairing zonular ligaments remains a significant global issue. Ocular tissue and aqueous humour samples from patients with EL were subjected to RNA sequencing and Olink high-throughput proteomic analysis, revealing the downregulation of pathogenic genes (, ) and upregulation of secretory proteins (IL-12, MMP-1). The high expression of and in NPCECs suggests their potential as candidates for zonular fiber construction; however, the limited availability of donor sources restricts the feasibility of NPCEC transplantation therapy. The reprogramming and directional differentiation of induced pluripotent stem cells (iPSC) to NPCEC was successfully achieved using the developed biomimetic scaffolds that mimic the microstructures of natural radial zonular fibers. Excitingly, the single injection of induced NPCEC-like cells significantly contributed to restoring and enhancing mechanical properties in zonular fiber structures in a rabbit model with EL. This proposed iPSC-based regeneration technique might serve as an innovative therapeutic strategy for clinical EL patients, reduce the cataract surgery rate, and retain the adjustment capacity of inherent lentis.
晶状体异位(EL)的特征是源自非色素睫状上皮细胞(NPCEC)的小带纤维受损,其带来了巨大的手术复杂性和视力损害的潜在风险。白内障手术是治疗EL的唯一方法,但术后会导致晶状体调节能力丧失。此外,修复小带韧带的挑战仍然是一个重大的全球性问题。对EL患者的眼组织和房水样本进行RNA测序和Olink高通量蛋白质组分析,揭示了致病基因(,)的下调和分泌蛋白(IL-12、MMP-1)的上调。和在NPCECs中的高表达表明它们作为小带纤维构建候选物的潜力;然而,供体来源的有限可用性限制了NPCEC移植治疗的可行性。使用模拟天然放射状小带纤维微观结构的仿生支架成功实现了诱导多能干细胞(iPSC)向NPCEC的重编程和定向分化。令人兴奋的是,单次注射诱导的类NPCEC细胞对恢复和增强EL兔模型中小带纤维结构的力学性能有显著作用。这种基于iPSC的再生技术可能为临床EL患者提供一种创新的治疗策略,降低白内障手术率,并保留晶状体的固有调节能力。